Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

Scott A. Armstrong, Jane Staunton, Lewis B. Silverman et al. · Nature Genetics · 2001 · 1.7K citations

Life Sciences, Genetics, Molecular Genetics +16

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

Jacques J. M. van Dongen, Taku Seriu, E. Renate Panzer-Grümayer et al. · The Lancet · 1998 · 961 citations

Medicine, Hematology, Oncology +14

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data

Vincent H. J. van der Velden, Giovanni Cazzaniga, André Schrauder et al. · Leukemia · 2007 · 700 citations · Full text

Life Sciences, Molecular Biology, Pathology +14

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

Rob Pieters, Martin Schrappe, Paola De Lorenzo et al. · The Lancet · 2007 · 653 citations

Medicine, Hematology, Pediatrics +14

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia

Monika Brüggemann, Thorsten Raff, Thomas Flohr et al. · Blood · 2005 · 537 citations

Medicine, Hematology, Oncology +16